穿戴式註射器市场规模、份额、成长分析、按类型、按技术、按适应症、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球穿戴式註射器市场规模为66.6亿美元，从2023年的76.5亿美元扩大到2031年的238.9亿美元，预测期（2024-2031）预计复合年增长率为15.29%。

穿戴式註射器正在彻底改变患者照护，提高患者和医护人员的安全性，并显着降低与传统注射方法（例如插入和拔针）相关的风险。随着已开发国家和开发中国家的医疗保健成本不断上升，这种创新註射器提供了一种解决方案，可提供高品质、负担得起的医疗保健。患者可以在家中方便地进行皮下注射，从而减少医院就诊次数和相关费用。注射器的用户友好设计允许用户透过按钮启动设备，确保无缝针头插入。给药后，针头会自动缩回，因此不存在针刺伤的可能性。这项先进技术不仅提高了安全性，还简化了注射过程，使其成为现代医疗保健的重要组成部分。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究
• 客户和购买标准分析

穿戴式註射器市场规模：按类型和复合年增长率（2024-2031）

• 市场概况
• 体内穿戴式註射器
• 离体穿戴式註射器
• 装置专用穿戴式註射器

穿戴式註射器市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 弹簧底座
• 马达驱动
• 扩充电池
• 旋转泵
• 其他的

穿戴式註射器市场规模：按适应症和复合年增长率（2024-2031）

• 市场概况
• 糖尿病
• 免疫肿瘤学
• 心血管
• 慢性疼痛

穿戴式註射器市场规模：依最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院/诊所
• 居家护理
• 其他的

穿戴式註射器市场规模：按地区及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Becton Dickinson（BD）
• Insulet Corporation
• Ypsomed Holding AG
• Tandem Diabetes Care
• Enable Injections
• West Pharmaceutical Services
• Stevanato Group
• Eitan Medical
• Sensile Medical
• Buhler Motor
• United Therapeutics
• Dexcom
• CeQur
• Phillips-Medisize
• Medtronic
• Amgen
• Oval Medical Technologies
• Gerresheimer AG
• Terumo Corporation
• BioCorp

结论和建议

Global Wearable Injectors Market size was valued at USD 6.66 billion in 2022 and is poised to grow from USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period (2024-2031).

Wearable injectors are revolutionizing patient care by enhancing safety for both patients and healthcare workers, significantly mitigating risks associated with traditional injection methods, such as needle insertion and removal. As healthcare costs rise in both developed and developing nations, these innovative injectors present a solution for delivering high-quality, affordable care. Patients can administer subcutaneous injections conveniently at home, reducing hospital visits and associated costs. With a user-friendly design, the injector allows users to activate the device with a button, ensuring seamless needle insertion. After medication delivery, the device retracts the needle automatically, eliminating the possibility of needle stick injuries. This advanced technology not only enhances safety but also streamlines the injection process, making it an essential component of modern healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Wearable Injectors market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Wearable Injectors Market Segmental Analysis

Global Wearable Injectors Market is segmented by Type, Technology, Indications, End User and region. Based on Type, the market is segmented into On-body Wearable Injectors, Off-body Wearable Injectors, Device-Only Wearable Injectors. Based on Technology, the market is segmented into Spring-Based, Motor Drive, Expanding Battery, Rotary Pump, Other. Based on Indications, the market is segmented into Diabetes, Immuno- Oncology, Cardiovascular, Chronic Pain. Based on End User, the market is segmented into Hospital & Clinic, Homecare, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Wearable Injectors Market

The growing prevalence of chronic diseases significantly fuels the expansion of the wearable injectors market. With a rise in the number of patients suffering from conditions such as diabetes, cardiovascular diseases, and cancer, the demand for these devices is surging. Wearable injectors offer a more convenient and less painful method for medication administration, which enhances patient adherence to treatment regimens. As the global burden of chronic illnesses escalates, particularly among the aging population, the adoption of wearable injectors is projected to rise. This trend reflects a broader shift toward innovative healthcare solutions that prioritize patient comfort and compliance.

Restraints in the Global Wearable Injectors Market

A significant constraint facing the global wearable injectors market is the elevated pricing associated with these devices. The integration of advanced technology and intricate manufacturing processes contributes to their high cost, rendering them less accessible to many users. This economic barrier presents a considerable challenge, particularly in developing and low-income regions, where affordability becomes a critical issue. As a result, the high prices of wearable injectors can hinder widespread adoption and limit market growth, creating disparities in access to these innovative healthcare solutions in different parts of the world.

Market Trends of the Global Wearable Injectors Market

The Global Wearable Injectors market is witnessing a significant trend towards personalized medicine, driven by the increasing development of biopharmaceutical products tailored to individual patient needs. As healthcare providers and manufacturers focus on delivering customized treatment regimens, wearable injectors are evolving to accommodate personalized medication delivery systems. This shift enhances patient outcomes by ensuring greater adherence and accuracy in drug administration. Furthermore, the rising demand for patient-centric solutions is revitalizing the market, fostering innovation in wearable injector technology that aligns with the broader trend of precision medicine, ultimately shaping the future of therapeutic delivery in healthcare.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis

Global Wearable Injectors Market Size by Type & CAGR (2024-2031)

• Market Overview
• On-body Wearable Injectors
• Off-body Wearable Injectors
• Device-Only Wearable Injectors

Global Wearable Injectors Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Spring-Based
• Motor Drive
• Expanding Battery
• Rotary Pump
• Other

Global Wearable Injectors Market Size by Indications & CAGR (2024-2031)

• Market Overview
• Diabetes
• Immuno- Oncology
• Cardiovascular
• Chronic Pain

Global Wearable Injectors Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospital & Clinic
• Homecare
• Other

Global Wearable Injectors Market Size & CAGR (2024-2031)

• North America, (Type, Technology, Indications, End User)
  • US
  • Canada
• Europe, (Type, Technology, Indications, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Type, Technology, Indications, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Type, Technology, Indications, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Type, Technology, Indications, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Becton Dickinson (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enable Injections
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eitan Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensile Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Buhler Motor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phillips-Medisize
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oval Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation